The Hidden Health Toll of Where We Spend 90% of Our Lives
We spend 90% of our lives in buildings. Ishita Das of the Milken Institute explains why that number should change how funders think.
A growing body of evidence shows that specific design features move our stress hormones, focus, and brain activity. The science exists in pockets. What has been missing is a field to hold it together, and the capital to build one.
If this bottleneck vanished tomorrow, what would break that nobody’s watching right now?
Why Cheap Generic Drugs Never Make It to Cancer Patients
Some of the most promising cancer treatments are not multibillion-dollar new discoveries. They are affordable generics already sitting on pharmacy shelves, backed by published data but lacking a commercial sponsor to bring them forward.
Dr. Laura Kleiman of Reboot Rx built a nonprofit to fix this market failure, using AI to sift through half a million studies and surface high-potential treatments. Proof that a treatment works does not guarantee it reaches patients, meaning clinical adoption requires its own deliberate investment.
What decision are you about to lock in that isn’t really yours to make?
For more than two decades, Andrew Wolk helped social sector organizations build better strategies, measure their work, and strengthen their impact. But one question kept nagging at him: If so many organizations were reporting success, why weren’t more people’s lives getting better?
Across the communities he studied, progress on outcomes like education and housing remained stubbornly slow, and in some places, things were getting worse.
Which led him to ask: What if we’ve been optimizing for the wrong things?
Today, through Finding Common Purpose, Andrew is putting that idea into practice, helping communities focus on what would actually make life better for the people who live and work there.
It’s Andrew Wolk on The Business of Giving.